202 related articles for article (PubMed ID: 34636313)
1. Therapeutic Potential of Indole Derivatives as Anti-HIV Agents: A Mini-review.
Chen Q; Wu C; Zhu J; Li E; Xu Z
Curr Top Med Chem; 2022; 22(12):993-1008. PubMed ID: 34636313
[TBL] [Abstract][Full Text] [Related]
2. 1,2,3-Triazole hybrids with anti-HIV-1 activity.
Feng LS; Zheng MJ; Zhao F; Liu D
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000163. PubMed ID: 32960467
[TBL] [Abstract][Full Text] [Related]
3. Developments of indoles as anti-HIV-1 inhibitors.
Xu H; Lv M
Curr Pharm Des; 2009; 15(18):2120-48. PubMed ID: 19519449
[TBL] [Abstract][Full Text] [Related]
4. Recent development of new substituted indole and azaindole derivatives as anti-HIV agents.
Ölgen S
Mini Rev Med Chem; 2013 Oct; 13(12):1700-8. PubMed ID: 23895189
[TBL] [Abstract][Full Text] [Related]
5. Coumarin-based derivatives with potential anti-HIV activity.
Xu Z; Chen Q; Zhang Y; Liang C
Fitoterapia; 2021 Apr; 150():104863. PubMed ID: 33582266
[TBL] [Abstract][Full Text] [Related]
6. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity.
Jia Y; Wen X; Gong Y; Wang X
Eur J Med Chem; 2020 Aug; 200():112359. PubMed ID: 32531682
[TBL] [Abstract][Full Text] [Related]
7. Novel indole based NNRTIs with improved potency against wild type and resistant HIV.
Müller R; Mulani I; Basson AE; Pribut N; Hassam M; Morris L; van Otterlo WAL; Pelly SC
Bioorg Med Chem Lett; 2014 Sep; 24(18):4376-4380. PubMed ID: 25176191
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in indole dimers and hybrids with antibacterial activity against methicillin-resistant Staphylococcus aureus.
Meng T; Hou Y; Shang C; Zhang J; Zhang B
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000266. PubMed ID: 32986279
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 integrase: a target for new AIDS chemotherapeutics.
Anthony NJ
Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
[TBL] [Abstract][Full Text] [Related]
10. Newly approved integrase inhibitors for clinical treatment of AIDS.
Gu WG
Biomed Pharmacother; 2014 Oct; 68(8):917-21. PubMed ID: 25451165
[TBL] [Abstract][Full Text] [Related]
11. Progress of bis(heteroaryl)piperazines (BHAPs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) against human immunodeficiency virus type 1 (HIV-1).
Xu H
Mini Rev Med Chem; 2010 Jan; 10(1):62-72. PubMed ID: 20380641
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication.
Maeda K; Das D; Kobayakawa T; Tamamura H; Takeuchi H
Curr Top Med Chem; 2019; 19(18):1621-1649. PubMed ID: 31424371
[TBL] [Abstract][Full Text] [Related]
13. Drugs for AIDS.
Ray S; Fatima Z; Saxena A
Mini Rev Med Chem; 2010 Feb; 10(2):147-61. PubMed ID: 20408798
[TBL] [Abstract][Full Text] [Related]
14. The development of anti-HIV-1 drugs.
Lu XF; Chen ZW
Yao Xue Xue Bao; 2010 Feb; 45(2):165-76. PubMed ID: 21348415
[TBL] [Abstract][Full Text] [Related]
15. Indole/isatin-containing hybrids as potential antibacterial agents.
Song F; Li Z; Bian Y; Huo X; Fang J; Shao L; Zhou M
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000143. PubMed ID: 32667714
[TBL] [Abstract][Full Text] [Related]
16. Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.
Famiglini V; Silvestri R
Antivir Chem Chemother; 2018; 26():2040206617753443. PubMed ID: 29417826
[TBL] [Abstract][Full Text] [Related]
17. Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928).
Li X; Gao P; Zhan P; Liu X
Expert Opin Ther Pat; 2016 May; 26(5):629-35. PubMed ID: 26742549
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Computer-aided Antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H.
Yang F; Yang J; Zhang Z; Tu G; Yao X; Xue W; Zhu F
Curr Med Chem; 2022; 29(10):1664-1676. PubMed ID: 34238145
[TBL] [Abstract][Full Text] [Related]
19. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
Zheng PR; Xue H; Xiao ZY; Liu G
Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
